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Preface for the special issue of imaging brain aging and neurodegenerative disease☆Nearly 10,000 people a day turn 65 in the United States, and as the
percentage of the population who are elderly continues to rise, in-
creasing numbers of individuals will be at risk for dementia. The
high costs of caring for seniors with cognitive decline call for better
evidence-based health recommendations and treatments. These im-
proved measures will require a greater understanding of the brain
mechanisms that distinguish between normal aging and dementia.
At present, dementia remains a clinical diagnosis. However, over the
past decade, neuroimaging research has yielded important new infor-
mation that promises to sharpen and better support clinical diagnosis.
Objective neuroimaging biomarkers may be of particular importance
if they can identify early dementia states, when emerging interven-
tions are most likely to be successful. In keeping with this view,
newly proposed criteria for Alzheimer's disease (AD) support the
use of neuroimaging to identify cognitively normal individuals who
are at imminent risk for the future development of AD (http://
www.alz.org/research/diagnostic_criteria/).
In this special issue of BBA Molecular Bases of Disease on ‘Imaging
brain aging and neurodegenerative disease’, leading experts review
patterns of neural decline that characterize normal aging and some
of the most common forms of dementia. The majority of articles will
focus on Alzheimer's disease (AD) because it is the most prevalent
form of dementia. However, neuroimaging proﬁles associated with
other common dementias such as frontotemporal dementia (FTD)
and vascular dementia will also be reviewed. Each of these dementias
is likely to involve multiple pathologies, causing multiple forms of
neurodegeneration. These different forms of neurodegeneration and
underlying pathologies can be optimally appreciated by speciﬁc neu-
roimaging techniques. Thus, a key focus of the present special issue is
to highlight how the use of speciﬁc neuroimaging techniques has im-
proved our knowledge about patterns of neurodegeneration associat-
ed with aging and various forms of dementia.
The most readily apparent change affecting the aging brain is corti-
cal atrophy resulting from synaptic and neuronal loss, which can be
quantiﬁed with volumetric magnetic resonance imaging (MRI). Anoth-
er visibly apparent structural change is the appearance of lesions with-
in white matter. These present as hyperintense patchy or conﬂuent
areas on FLAIR images that reﬂect vascular effects, some of which
may compromise cognition or processing speed [1]. The recent devel-
opment of several other neuroimaging sequences has enabled assess-
ment of age-related cerebral changes not captured by conventional
MRI techniques. For example, diffusion tensor imaging (DTI) methods
now provide a window into white matter damage at microstructural
levels [2]. A relatively new and highly promising technique is positron
emission tomography (PET) with protein-speciﬁc radiolabeled ligands☆ This article is part of a Special Issue entitled: Imaging Brain Aging and Neurodegen-
erative Disease.
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doi:10.1016/j.bbadis.2012.01.001[3]. Such techniques can image ﬁbrillar beta-amyloid cortical accumu-
lations, representing an in-vivo window into brain pathology. Finally,
various applications of PET or functional MRI (fMRI), allow for the as-
sessment of age-related changes in metabolic or synaptic function.
In this special issue, cerebral atrophy patterns associated with pre-
symptomatic stages of AD are reviewed by Smith, while atrophy pat-
terns associated with early FTD are reviewed by Roher et al. An
original contribution by Burns et al. shows that insulin resistance dif-
ferentially affects brain structure in normal aging and AD. The role of
vascular factors and white matter hyperintensities (WMH) in AD is
reviewed by de Leeuw et al., and the use of specialized iron sensitive
MRI sequences to detect neurodegenerative conditions associated
with brain iron accumulation is reviewed by Schipper. The original
contribution of Raz et al. presents new evidence that certain genetic
factors that promote inﬂammation contribute toWMHs in healthy se-
niors. The importance of amyloid imaging in the diagnoses of pre-
symptomatic AD is covered by John Morris's group (Vlassenko et
al.). An original contribution by Agneta Norberg's group (Forsberg et
al.) provides evidence that a single dynamic amyloid label PIB-PET
scan can provide a time-sensitive biomarker of early AD.
A total of ﬁve articles are devoted to the exploration of WMmicro-
structural changes in aging and/or dementia. Madden et al. provide a
comprehensive review of the literature on patterns of WM integrity
changes associated with normal aging. An original contribution of
van Norden et al. from a large prospectively followed cohort of
healthy seniors (N=503) demonstrates signiﬁcant relationships be-
tween WM integrity and both memory functioning and psychomotor
speed. An original contribution from Lars Nyberg's group (Salami et
al.) suggests that age-related WM integrity declines may have stron-
ger effects on psychomotor processing speed than cognition. Gold et
al. review ﬁndings suggesting that WM integrity changes are present
in normal individuals at high risk for future AD. Interestingly, an orig-
inal contribution from Andrew Saykin's group (Wang et al.) shows
that WM integrity declines are evident in normal seniors with cogni-
tive complaints, providing further evidence of DTI's utility in the de-
tection of prodromal AD-states.
Functional brain imaging articles include reviews of default mode
brain imaging changes in aging and dementia by Serge Rombouts's
group (Hafkemeijer et al.). Alterations in default mode are promising
as potential functional biomarkers because they capture dementia-
related changes when subjects are at rest, and thus do not reﬂect
overt difﬁculties in task performance frequently encountered in de-
mentia. An interesting alterative, or complementary, functional para-
digm may be one showing robust activation changes on a task
performed near ceiling in early dementia states. In this vein, Woodard
et al. review evidence suggesting that functional activation alterations
during semantic tasks may represent a useful biomarker of presymp-
tomatic AD because performance on this task remains intact in early
316 PrefaceAD states. Concerning other functional imagingmodalities, an original
contribution by Steven Potkin's group (Rasmussen et al.), describes a
method for empirical derivation of the denominator region for com-
puting degeneration sensitive FDG-PET ratios in AD.
It is important to note that the potential of neuroimaging goes far
beyond identiﬁcation of early dementia states. For example, one of
the remarkable insights that neuroimaging research has provided
over the last 20 years is to show that the brain does not merely re-
spond passively to age- and dementia-related declines. Neuroimaging
studies have demonstrated that individuals with higher cognitive re-
serve (e.g., higher education) can tolerate more AD pathology than
those with lower reserve and still appear clinically normal [4]. In
this special issue, Stern's group (Steffener et al.) review neuroimaging
ﬁndings suggesting that cognitive reserve may operate through two
brain mechanisms: structural variables termed neural reserve and
functional variables termed neural compensation. An open question
concerns how positive lifestyle variables may bolster cerebral reserve.
In this special issue, Lautenschlager et al. review the literature on
physical activity as a protective factor in aging, and the review of
Wang et al. summarizes the potential beneﬁts of stimulating leisure
activities in delaying age-related declines.
We hope that these articles provide a stimulating and thought-
provoking collection of works on cutting edge research in the ﬁeld
of neuroimaging of aging and dementia. We would like to thank ev-
eryone who has contributed to this special issue. Firstly, thanks to
the authors for their excellent contributions. Secondly, thanks to the
reviewers: their time and effort improved the quality of the ﬁnal arti-
cles. Last, but not least, thanks to the editorial staff of BBA for their
help in the compiling and production of this special issue.
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